- Home
- NNOX vs KPTI Comparison
NNOX vs KPTI Comparison
Compare NNOX & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNOX | KPTI |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 172.6M |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NNOX | KPTI |
|---|---|---|
| Price | $2.21 | $5.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $7.00 | ★ $15.33 |
| AVG Volume (30 Days) | 593.1K | ★ 1.2M |
| Earning Date | 03-31-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $146,067,000.00 |
| Revenue This Year | $20.19 | N/A |
| Revenue Next Year | $137.69 | $46.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $2.11 | $3.51 |
| 52 Week High | $5.72 | $10.99 |
Technical Indicators
Market Signals| Indicator | NNOX | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 30.03 |
| Support Level | $2.11 | $3.93 |
| Resistance Level | $2.75 | $6.96 |
| Average True Range (ATR) | 0.12 | 0.88 |
| MACD | -0.03 | -0.39 |
| Stochastic Oscillator | 6.36 | 11.14 |
Price Performance
Historical ComparisonAbout NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).